StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Bluejay Diagnostics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bluejay Diagnostics's price to book ratio was 0.6× on Nov 11, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.0× to 5.0×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×+0.3
2025Dec 31, 20250.3×−0.7
2024Dec 31, 20241.0×−0.2
2023Dec 29, 20231.2×−1.1
2022Dec 30, 20222.2×–

More Bluejay Diagnostics figures

See a number that looks wrong?